Status:
COMPLETED
Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis
Lead Sponsor:
Baxter Healthcare Corporation
Conditions:
Femoral Vascular Anastomosis
Eligibility:
All Genders
Brief Summary
This study investigates if the time to hemostasis can be reduced by application of Tissucol® onto femoral vascular anastomoses with PTFE prostheses compared to standard methods, such as compression wi...
Eligibility Criteria
Inclusion
- Subjects with femoral vascular anastomosis and bleeding suture holes after vessel reconstruction with a PTFE prosthesis
Exclusion
Key Trial Info
Start Date :
September 1 2003
Trial Type :
OBSERVATIONAL
End Date :
February 1 2004
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00163592
Start Date
September 1 2003
End Date
February 1 2004
Last Update
October 23 2006
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital (AKH) Salzburg
Salzburg, Salzburg, Austria, 5020
2
Landeskrankenhaus Innsbruck
Innsbruck, Tyrol, Austria, 6020
3
Leonberg Hospital, Department of Vascular Surgery
Leonberg, Germany, 71229
4
University Clinics of Magdeburg, Department of Vascular Surgery
Magdeburg, Germany, 39120